|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
AMLN » Topics » So as far as I am aware the meeting, there is two days. One is on saxagliptin and then the second day is on liraglutide. And the agenda for those two days hasnt yet been set or, sorry, should not say, has not yet been published.This excerpt taken from the AMLN DEFA14A filed Mar 18, 2009. So as far as I am aware the meeting, there is two days. One is on saxagliptin and then the second day is on liraglutide. And the agenda for those two days hasnt yet been set or, sorry, should not say, has not yet been published.
Unidentified Audience Member
(inaudible question - microphone inaccessible)
Dan Bradbury - Amylin Pharmaceuticals, Inc. - President & CEO
|
| |||||||